Profound Medical
NASDAQ: PROF
$7.25 ▲ +0.40  (+5.84%)
At close: Jul 24, 2026 · 3:59 PM UTC
Financial Ratios
Market Cap248.64 Mn
P/E4.12
P/S13.38
Div. Yield0.00
ROIC (Qtr)-0.06
Total Debt (Qtr)9.01 Mn
Revenue Growth (1y) (Qtr)103.62
Add ratio to table…

About

Profound Medical Corp. is a commercial stage medical device company focused on the development and marketing of AI powered, MRI guided, and incision free therapies for the ablation of diseased tissue. The company’s lead product, the TULSA PRO system, combines real time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed loop temperature feedback control to ablate whole gland or physician defined regions of malignant or benign prostate…

Read more ↓
Sector: Healthcare Industry: Medical Devices CIK: 0001628808

Geographical Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Companies in the Medical Devices
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ABT Abbott Laboratories 201.40 Bn27.984.4634.05 Bn
2 SYK Stryker Corp 122.29 Bn36.604.8414.72 Bn
3 MDT Medtronic plc 105.01 Bn21.732.8927.96 Bn
4 BSX Boston Scientific Corp 64.81 Bn18.163.1411.03 Bn
5 EW Edwards Lifesciences Corp 55.28 Bn2,354.768.770.60 Bn
6 DXCM Dexcom Inc 29.06 Bn29.176.03-
7 PHG Koninklijke Philips Nv 29.02 Bn22.061.429.48 Bn
8 GEHC GE HealthCare Technologies Inc. 28.27 Bn14.301.3510.14 Bn